Today's Research Reports on Sernova, Covalon Technologies, CRH Medical and Cotinga Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / November 29, 2018 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.
The Market Edge Initiates Coverage on:
Sernova Corp.
https://marketedgereport.com/report/SVA.V/
Covalon Technologies Ltd.
https://marketedgereport.com/report/COV.V/
CRH Medical Corporation
https://marketedgereport.com/report/CRH.TO/
Cotinga Pharmaceuticals Inc.
https://marketedgereport.com/report/COT.V/
Sernova’s stocks jumped 9.76% Wednesday, to close the day at $0.225. The stock recorded a trading volume of 246,250 shares, which was above its three months average volume of 169,206 shares. In the last year, Sernova's shares have traded in a range of 0.17 - 0.51. The share price has gained 32.35% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.201 is lower than its 200-day moving average of $0.222. Shares of Sernova have fallen approximately 46.43 percent year-to-date.
Access The Market Edge's Sernova Corp. Research Report:
https://marketedgereport.com/report/SVA.V/
On Wednesday, shares of Covalon Technologies recorded a trading volume of 3,950 shares, which was below the three months average volume of 30,947 shares. The stock ended the day 2.08% lower at $5.64. The share price has fallen 40.32% from its 52 week high with a 52 week trading range of 3.22 - 9.45. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $8.23 is greater than its 200-day moving average of $7.23. Shares of the company are trading at a Price to Earnings ratio of 45.85. Shares of Covalon Technologies have gained approximately 15.34 percent year-to-date.
Access The Market Edge's Covalon Technologies Ltd. Research Report:
https://marketedgereport.com/report/COV.V/
CRH Medical’s stock jumped 4.16% Wednesday, to close the day at $4.51. The stock recorded a trading volume of 331,984 shares, which was above its three months average volume of 204,823 shares. In the last year, CRH Medical's shares have traded in a range of 2.33 - 5.91. The share price has gained 93.56% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.22 is lower than its 200-day moving average of $4.58. Shares of the company are trading at a Price to Earnings ratio of 53.06. Shares of CRH Medical have gained approximately 36.25 percent year-to-date.
Access The Market Edge's CRH Medical Corporation Research Report:
https://marketedgereport.com/report/CRH.TO/
On Wednesday, shares of Cotinga Pharmaceuticals recorded a trading volume of 100,800 shares, which was above the three months average volume of 73,339 shares. The stock ended the day 16.67% higher at $0.07. The share price has fallen 94.81% from its 52 week high with a 52 week trading range of 0.05 - 1.35. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.08 is lower than its 200-day moving average of $0.36. Shares of Cotinga Pharmaceuticals have fallen approximately 93.64 percent year-to-date.
Access The Market Edge's Cotinga Pharmaceuticals Inc. Research Report:
https://marketedgereport.com/report/COT.V/
Our Actionable Research on Sernova Corp. (TSXV:SVA.V), Covalon Technologies Ltd. (TSXV:COV.V), CRH Medical Corporation (TSX:CRH.TO) and Cotinga Pharmaceuticals Inc. (TSXV:COT.V) can be downloaded free of charge at The Market Edge.
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Edge